Experience of 30 cases of community care for tuberculosis.docVIP

 PAGE \* MERGEFORMAT 9 Experience of 30 cases of community care for tuberculosis [Keywords:] TB community care In recent years, putting in a lot of China’s human and financial resources to prevent and control tuberculosis has made some achievements, but TB is not only in remote regions and economically underdeveloped regions, the high incidence, but also in the suburbs and the economy is relatively developed areas, the incidence rate on the rise. Our hospital is located at the junction of urban and rural areas, will now be admitted to our hospital in recent years, 30 cases of pulmonary tuberculosis on the experience of community care for an introduction. A clinical data 1.1 General Information 30 patients were in January 2004 -2,008 year in October our hospital out-patients, were confirmed by the district CDC. 12 males and 18 female cases; aged 18 to 40 years old in 6 cases, 40 to 60 years in 22 cases, 60 to 75-year-old two cases; Ⅰ type 4 cases, Ⅲ in 24 cases, Ⅴ type 2 cases; smear 21 cases of newly diagnosed smear-negative in 7 cases, re-treatment smear-positive in 2 cases. 30 cases of patients with varying degrees of cough, sputum, night sweats, hemoptysis, or sputum with blood, loss of appetite, weight loss, nausea, fatigue, lassitude. 60 ~ 75 age group of the patients had a history of two cases of chronic bronchitis, hypertension in 1 case, without serious complications, cardiopulmonary function can still be. 1.2 Treatment 1.2.1 The group was treated with anti-tuberculosis treatment and community care. (1) anti-tuberculosis treatment: 21 cases of smear-positive patients using the program 2H3R3Z3E3/4H3R3. ① strengthening period: isoniazid, rifampicin, pyrazinamide, ethambutol one dose every other day, sharing 2 months. ② continued period: isoniazid, rifampicin, one dose every other day, sharing 4 months, full 6 months. 7 cases of newly diagnosed patients with smear-negative 2H3R3Z3/4H3R3. ① strengthening period: isoniazid, rifampicin, pyrazinami